Ocera Therapeutics (OCRX) Misses Q1 EPS by 3c

Ocera Therapeutics (NASDAQ: OCRX) reported Q1 EPS of ($0.36), $0.03 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $33 thousand versus the consensus estimate of $10 thousand.

For earnings history and earnings-related data on Ocera Therapeutics (OCRX) click here.

You May Also Be Interested In

• CrowdStrike shares jump on earnings beat, raised outlook
• Veeva Systems (VEEV) Tops Q2 EPS by 13c; Offers Guidance
• Berenberg Downgrades Admiral Group Plc. (ADM:LN) (AMIGY) to Hold